Treatment of mood disorders (Q34982300)

5 August 2017

1 reference

title

Treatment of mood disorders (English)

1 reference

5 August 2017

Charles B Nemeroff

1

1 reference

5 August 2017

Michael J Owens

series ordinal

2

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

5 August 2017

1 reference

5 August 2017

volume

5 Suppl

1 reference

5 August 2017

page(s)

1068-1070

1 reference

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

5 August 2017

cites work

1 reference

7 January 2021

Research: Methods, Mechanisms, and Causes Introduction

1 reference

7 January 2021

Birth-cohort trends in rates of major depressive disorder among relatives of patients with affective disorder.

1 reference

7 January 2021

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

1 reference

7 January 2021

Depression following myocardial infarction. Impact on 6-month survival.

1 reference

7 January 2021

Depression and 18-month prognosis after myocardial infarction.

1 reference

7 January 2021

A Molecular and Cellular Theory of Depression

1 reference

7 January 2021

cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment.

1 reference

7 January 2021

Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo

1 reference

7 January 2021

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

1 reference

7 January 2021

Role of norepinephrine in the pathophysiology and treatment of mood disorders

1 reference

7 January 2021

Lower dopamine transporter binding potential in striatum during depression

1 reference

7 January 2021

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

1 reference

7 January 2021

Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low.

1 reference

7 January 2021

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression

1 reference

7 January 2021

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

7 January 2021

Rapid reversal of psychotic depression using mifepristone

1 reference

7 January 2021

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

1 reference

7 January 2021

Neurokinin(1) receptor antagonists as potential antidepressants

1 reference

7 January 2021

Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study

1 reference

7 January 2021

Identifiers

DOI

10.1038/NN943

1 reference

Dimensions Publication ID

5 August 2017

1043566581

0 references

Fatcat ID

release_yesq23hmunh2lce6dawxbhja6y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yesq23hmunh2lce6dawxbhja6y

24 November 2022

mapped directly with Wikidata item

1 reference